Cidara Therapeutics (CDTX) Prices 2.48M Common Stock Offering at $10.10/Share

Cidara Therapeutics (CDTX) to Offer Common Stock

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has commenced an underwritten public offering of its common stock. Cidara also expects to grant the underwriter of the offering a 30-day option to purchase... More